Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma- A Multi-Center Validation Study

NCT05078853 is registered in ClinicalTrials.gov with Soroka University Medical Center as lead sponsor.

NCT NCT05078853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05078853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma- A Multi-Center Validation Study
Lead sponsor
Soroka University Medical Center
Phase
Observational
Overall status
Completed
Start date
October 6, 2021
Completion date
April 22, 2026
Enrollment
250 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

differentiated thyroid cancer, lymph node metastases